Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
MSVMX vs GDOC
Shared holdings
9
MSVMX covered by GDOC
25.69%
GDOC covered by MSVMX
25.69%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 33 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
MSVMX (March 31, 2026)
| Security | Weight | |
|---|---|---|
| ARGENX SE SPONSORED ADR | 8.35% | |
| LILLY ELI and CO | 8.10% | |
| Ascendis Pharma A/S | 5.70% | |
| NEKTAR THERAPEUTICS | 4.94% | |
| THERMO FISHER SCIENTIFIC INC | 4.45% | |
| ALIGN TECHNOLOGY INC | 4.34% | |
| ENLIVEN THERAPEUTICS INC | 4.05% | |
| 10X GENOMICS INC | 3.92% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 3.71% | |
| STRUCTURE THERAPEUTICS INC ADR | 3.49% | |
| CERIBELL INC | 3.49% | |
| DOXIMITY INC-A | 3.05% | |
| INTUITIVE SURGICAL INC | 2.96% | |
| GUARDANT HEALTH INC | 2.83% | |
| ALNYLAM PHARMACEUTICALS INC | 2.82% | |
| VERTEX PHARMACEUTICALS INC | 2.78% | |
| VAXCYTE INC | 2.69% | |
| ILLUMINA INC | 2.62% | |
| INSPIRE MEDICAL SYSTEMS INC | 2.58% | |
| ZOETIS INC CL A | 2.36% | |
| UNITEDHEALTH GRP | 2.26% | |
| KYMERA THERAPEUTICS INC | 2.16% | |
| DEXCOM INC | 2.07% | |
| BEAM THERAPEUTICS INC | 1.86% | |
| WEST PHARMACEUTICAL SVCS INC | 1.78% | |
| ATAIBECKLEY INC | 1.70% | |
| MAXCYTE INC | 1.69% | |
| VEEVA SYSTEMS-A | 1.62% | |
| MSILF-TR SEC-INS | 1.59% | |
| SCHRODINGER INC | 1.41% | |
| TEMPUS AI INC-A | 1.27% | |
| ULTRAGENYX PHARMA INC | 0.77% | |
| UNIQURE N.V. | 0.59% |
GDOC (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 12.20% | |
| JOHNSON&JOHNSON | 8.10% | |
| ASTRAZENECA PLC | 6.41% | |
| MERCK & CO | 5.99% | |
| BOSTON SCIENTIFIC CORP | 5.81% | |
| THERMO FISHER SCIENTIFIC INC | 4.62% | |
| INTUITIVE SURGICAL INC | 4.47% | |
| GUARDANT HEALTH INC | 3.73% | |
| HOYA CORP | 3.63% | |
| ARGENX SE SPONSORED ADR | 3.60% | |
| CENCORA INC | 3.39% | |
| ABBOTT LABS | 3.13% | |
| LONZA GROUP -REG | 2.94% | |
| AGILENT TECHNOLOGIES INC | 2.91% | |
| DEXCOM INC | 2.68% | |
| ROIVANT SCIENCES LTD | 2.23% | |
| METTLER-TOLEDO INTL INC | 1.77% | |
| APOGEE THERAPEUTICS INC | 1.62% | |
| Sartorius Stedim Biotech S.A. | 1.59% | |
| IONIS PHARMACEUTICALS INC | 1.41% | |
| QIAGEN NV | 1.39% | |
| REPLIGEN CORP | 1.26% | |
| INSMED INC | 1.22% | |
| PENUMBRA INC | 1.14% | |
| Goldman Sachs Treasury Obligations Fund Institutional Class | 1.09% | |
| NATERA INC | 1.05% | |
| XENON PHARMACEUTICALS INC | 1.03% | |
| ROYALTY PHARMA PLC | 1.01% | |
| UNITEDHEALTH GRP | 1.01% | |
| CYTOKINETICS INC | 0.98% | |
| BRIDGEBIO PHARMA INC | 0.92% | |
| MADRIGAL PHARMACEUTICALS INC | 0.89% | |
| RHYTHM PHARMACEUTICALS INC | 0.88% | |
| CG ONCOLOGY INC | 0.83% | |
| ARCELLX INC | 0.82% | |
| GENEDX HOLDINGS CORP-A | 0.59% | |
| REVOLUTION MEDICINES INC | 0.52% | |
| INSULET CORP | 0.47% | |
| ULTRAGENYX PHARMA INC | 0.37% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.30% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.